MAXIMA GLOBAL PHARMACEUTICAL LTD. (SINGAPORE BRANCH)

Business Description

MAXIMA GLOBAL PHARMACEUTICAL LTD. (SINGAPORE BRANCH) is registered as a business entity on 10 October 2001 (23.3 years ago) structured as a Foreign Company Registered In Singapore (Foreign Company) with 2 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) T01FC6159H. The business official address is located at 46 Lorong 17 Geylang #02-01, Singapore 388568 in the primary industry of 46461: Wholesale Of Medicinal And Pharmaceutical Products (western) using Singapore Dollars - SGD as its default trading currency. The business name remains unchanged since inception. The business annual account filing date falls on 10 October and is no longer operational with the status of 'na'. The business paid up share capital is CAD 0, with preference share capital of CAD 0, and other share capital at CAD 0.

In the past 365 days, MAXIMA GLOBAL PHARMACEUTICAL LTD. (SINGAPORE BRANCH) has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is registered as a foreign company, it is the offshore branch of a parent orgnisation and more research should to be done to understand its local presence. The lack of an appointed auditor indicates that the business is small sized as it did not meet the regulatory requirements of revenue or assets exceeding SGD 10 million, or has more than 50 employees in the previous two fiscal years.

MAXIMA GLOBAL PHARMACEUTICAL LTD. (SINGAPORE BRANCH) is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023